Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Protein Kinase Inhibitor
Revenue, means the sales value of Protein Kinase Inhibitor
This report studies sales (consumption) of Protein Kinase Inhibitor in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Kyowa Hakko Kirin
Levolta Pharmaceuticals
Mabtech
Marsala Biotech
Neumedicines
Novartis
Oncobiologics
Onyx Pharmaceuticals
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Protein Kinase Inhibitor in each application, can be divided into
Application 1
Application 2
Application 3
United States Protein Kinase Inhibitor Market Report 2016
1 Protein Kinase Inhibitor Overview
1.1 Product Overview and Scope of Protein Kinase Inhibitor
1.2 Classification of Protein Kinase Inhibitor
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Protein Kinase Inhibitor
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Protein Kinase Inhibitor (2011-2021)
1.4.1 USA Protein Kinase Inhibitor Sales and Growth Rate (2011-2021)
1.4.2 USA Protein Kinase Inhibitor Revenue and Growth Rate (2011-2021)
2 USA Protein Kinase Inhibitor Competition by Manufacturers
2.1 USA Protein Kinase Inhibitor Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Protein Kinase Inhibitor Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Protein Kinase Inhibitor Average Price by Manufactures (2015 and 2016)
2.4 Protein Kinase Inhibitor Market Competitive Situation and Trends
2.4.1 Protein Kinase Inhibitor Market Concentration Rate
2.4.2 Protein Kinase Inhibitor Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Protein Kinase Inhibitor Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Protein Kinase Inhibitor Sales and Market Share by Type (2011-2016)
3.2 USA Protein Kinase Inhibitor Revenue and Market Share by Type (2011-2016)
3.3 USA Protein Kinase Inhibitor Price by Type (2011-2016)
3.4 USA Protein Kinase Inhibitor Sales Growth Rate by Type (2011-2016)
4 USA Protein Kinase Inhibitor Sales (Volume) by Application (2011-2016)
4.1 USA Protein Kinase Inhibitor Sales and Market Share by Application (2011-2016)
4.2 USA Protein Kinase Inhibitor Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Protein Kinase Inhibitor Manufacturers Profiles/Analysis
5.1 Pfizer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Protein Kinase Inhibitor Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Allergan
5.2.2 Protein Kinase Inhibitor Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Allergan Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Alnylam Pharmaceuticals
5.3.2 Protein Kinase Inhibitor Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Alnylam Pharmaceuticals Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Amgen
5.4.2 Protein Kinase Inhibitor Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Amgen Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Angstrom Pharmaceuticals
5.5.2 Protein Kinase Inhibitor Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Angstrom Pharmaceuticals Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Acceleron Pharma
5.6.2 Protein Kinase Inhibitor Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Acceleron Pharma Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Biocon
5.7.2 Protein Kinase Inhibitor Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Biocon Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bionomics
5.8.2 Protein Kinase Inhibitor Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bionomics Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 CASI Pharmaceuticals
5.9.2 Protein Kinase Inhibitor Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 CASI Pharmaceuticals Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Celgene Corporation
5.10.2 Protein Kinase Inhibitor Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Celgene Corporation Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Enzon Pharmaceuticals
5.12 Five Prime Therapeutics
5.13 Fujifilm Kyowa Kirin Biologics
5.14 Genentech
5.15 Genexine
5.16 Hetero Drugs
5.17 ImClone Systems
5.18 Intas Pharmaceuticals
5.19 Kyowa Hakko Kirin
5.20 Levolta Pharmaceuticals
5.21 Mabtech
5.22 Marsala Biotech
5.23 Neumedicines
5.24 Novartis
5.25 Oncobiologics
5.26 Onyx Pharmaceuticals
6 Protein Kinase Inhibitor Manufacturing Cost Analysis
6.1 Protein Kinase Inhibitor Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Protein Kinase Inhibitor
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Protein Kinase Inhibitor Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Protein Kinase Inhibitor Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Protein Kinase Inhibitor Market Forecast (2016-2021)
10.1 USA Protein Kinase Inhibitor Sales, Revenue Forecast (2016-2021)
10.2 USA Protein Kinase Inhibitor Sales Forecast by Type (2016-2021)
10.3 USA Protein Kinase Inhibitor Sales Forecast by Application (2016-2021)
10.4 Protein Kinase Inhibitor Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Protein Kinase Inhibitor
Table Classification of Protein Kinase Inhibitor
Figure USA Sales Market Share of Protein Kinase Inhibitor by Type in 2015
Table Application of Protein Kinase Inhibitor
Figure USA Sales Market Share of Protein Kinase Inhibitor by Application in 2015
Figure USA Protein Kinase Inhibitor Sales and Growth Rate (2011-2021)
Figure USA Protein Kinase Inhibitor Revenue and Growth Rate (2011-2021)
Table USA Protein Kinase Inhibitor Sales of Key Manufacturers (2015 and 2016)
Table USA Protein Kinase Inhibitor Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Protein Kinase Inhibitor Sales Share by Manufacturers
Figure 2016 Protein Kinase Inhibitor Sales Share by Manufacturers
Table USA Protein Kinase Inhibitor Revenue by Manufacturers (2015 and 2016)
Table USA Protein Kinase Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Protein Kinase Inhibitor Revenue Share by Manufacturers
Table 2016 USA Protein Kinase Inhibitor Revenue Share by Manufacturers
Table USA Market Protein Kinase Inhibitor Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Protein Kinase Inhibitor Average Price of Key Manufacturers in 2015
Figure Protein Kinase Inhibitor Market Share of Top 3 Manufacturers
Figure Protein Kinase Inhibitor Market Share of Top 5 Manufacturers
Table USA Protein Kinase Inhibitor Sales by Type (2011-2016)
Table USA Protein Kinase Inhibitor Sales Share by Type (2011-2016)
Figure USA Protein Kinase Inhibitor Sales Market Share by Type in 2015
Table USA Protein Kinase Inhibitor Revenue and Market Share by Type (2011-2016)
Table USA Protein Kinase Inhibitor Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Protein Kinase Inhibitor by Type (2011-2016)
Table USA Protein Kinase Inhibitor Price by Type (2011-2016)
Figure USA Protein Kinase Inhibitor Sales Growth Rate by Type (2011-2016)
Table USA Protein Kinase Inhibitor Sales by Application (2011-2016)
Table USA Protein Kinase Inhibitor Sales Market Share by Application (2011-2016)
Figure USA Protein Kinase Inhibitor Sales Market Share by Application in 2015
Table USA Protein Kinase Inhibitor Sales Growth Rate by Application (2011-2016)
Figure USA Protein Kinase Inhibitor Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alnylam Pharmaceuticals Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Angstrom Pharmaceuticals Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Acceleron Pharma Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Bionomics Basic Information List
Table Bionomics Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionomics Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table CASI Pharmaceuticals Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celgene Corporation Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Enzon Pharmaceuticals Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Five Prime Therapeutics Basic Information List
Table Five Prime Therapeutics Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Five Prime Therapeutics Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Genexine Basic Information List
Table Genexine Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genexine Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Hetero Drugs Basic Information List
Table Hetero Drugs Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hetero Drugs Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table ImClone Systems Basic Information List
Table ImClone Systems Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table ImClone Systems Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intas Pharmaceuticals Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowa Hakko Kirin Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Levolta Pharmaceuticals Basic Information List
Table Levolta Pharmaceuticals Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Levolta Pharmaceuticals Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Mabtech Basic Information List
Table Mabtech Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mabtech Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Marsala Biotech Basic Information List
Table Marsala Biotech Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Marsala Biotech Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Neumedicines Basic Information List
Table Neumedicines Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neumedicines Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Oncobiologics Basic Information List
Table Oncobiologics Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oncobiologics Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Onyx Pharmaceuticals Basic Information List
Table Onyx Pharmaceuticals Protein Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Onyx Pharmaceuticals Protein Kinase Inhibitor Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Protein Kinase Inhibitor
Figure Manufacturing Process Analysis of Protein Kinase Inhibitor
Figure Protein Kinase Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Protein Kinase Inhibitor Major Manufacturers in 2015
Table Major Buyers of Protein Kinase Inhibitor
Table Distributors/Traders List
Figure USA Protein Kinase Inhibitor Production and Growth Rate Forecast (2016-2021)
Figure USA Protein Kinase Inhibitor Revenue and Growth Rate Forecast (2016-2021)
Table USA Protein Kinase Inhibitor Production Forecast by Type (2016-2021)
Table USA Protein Kinase Inhibitor Consumption Forecast by Application (2016-2021)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...